Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Emig

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Molecular Recognition : JMR|December 18, 2001
Exploration of sequence space for protein engineeringC Gustafsson, S Govindarajan, R Emig
British Journal of Cancer|December 23, 1998
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferationR Emig, A Magener, V Ehemann, et al.
Zentralblatt Fur Gynakologie|August 15, 1998
[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support]E F Solomayer, I J Diel, G Meyberg, et al.
International Journal of Cancer|June 8, 2001
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patientsA Seute, H P Sinn, R F Schlenk, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Molecular Recognition : JMR|December 18, 2001
Exploration of sequence space for protein engineeringC Gustafsson, S Govindarajan, R Emig
British Journal of Cancer|December 23, 1998
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferationR Emig, A Magener, V Ehemann, et al.
Zentralblatt Fur Gynakologie|August 15, 1998
[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support]E F Solomayer, I J Diel, G Meyberg, et al.
International Journal of Cancer|June 8, 2001
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patientsA Seute, H P Sinn, R F Schlenk, et al.
Pageof 1